s.solberg
TL2 · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 27 April 2025 · last posted 6d
90Posts here
2Topics
0Solutions
239Likes received
325Likes given
18Badges
127Days visited
933Posts read
Most-liked posts
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #106 · Practice › Dosing & titration · 20 Feb 2026 · 32 likes Post #102 and I disagree about the size of the effect, not about the direction. The starting dose in most of these programmes is a tolerance step and produces little…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #37 · Compounds › Other compounds · 7 Oct 2024 · 32 likes Good question, well framed, and I would like to see it answered properly.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #27 · Practice › Dosing & titration · 21 Jun 2024 · 32 likes Post #24 answers the question as asked. The question underneath it is different. Two questions I would want answered before drawing anything from the four-week…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #66 · Sourcing › Regulatory · 2 Mar 2025 · 31 likes A compound in a compounding pathway in one country and unavailable in another is a common situation and produces most of the confusion here. One of those cases where…
-
CJC-1295 with and without DAC: what the modification does Replied, post #106 · Compounds › Secretagogues & GH axis · 8 Jul 2026 · 30 likes Right, and stated more narrowly than I would have dared to state it.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #110 · Documentation › Doc review · 11 Dec 2025 · 29 likes Post #107 is the version of this I will quote in future. One addition. The claim about Promotion criteria upthread is stronger than its source supports. I have read the…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 1 May 2025 |
| Read the Guidelines | bronze | 1 May 2025 |
| First Reply | bronze | 4 May 2025 |
| Welcome | bronze | 4 May 2025 |
| First Topic | bronze | 9 May 2025 |
| First Quote | bronze | 18 May 2025 |
| First Tag | bronze | 21 May 2025 |
| Asked Well | bronze | 22 May 2025 |
| Member | bronze | 25 May 2025 |
| First Link | bronze | 30 May 2025 |
| Generous | bronze | 9 Jun 2025 |
| Editor | bronze | 13 Jun 2025 |
| Reader | bronze | 10 Aug 2025 |
| Sourced | bronze | 18 Aug 2025 |
| Nice Post | bronze | 17 Oct 2025 |
| Nice Topic | bronze | 23 Nov 2025 |
| Good Post | silver | 4 Feb 2026 |
| Anniversary | silver | 27 Apr 2026 |